Cedars-Sinai names lung cancer specialist head of medical oncology

January 25, 2020
Karen L. Reckamp, MD, MS, has been named director of the division of medical oncology at Cedars-Sinai Cancer. Reckamp also will serve as associate…

In the Journals

CVS’ decision to stop cigarette sales likely led to more quit attempts

January 24, 2020
In 2014, CVS Health said it would stop selling tobacco products, suggesting that such sales contradicted the company’s goal of promoting…

Tislelizumab extends PFS in squamous non-small cell lung cancer

January 22, 2020
A randomized phase 3 trial designed to evaluate the addition of tislelizumab to first-line chemotherapy for patients with squamous non-small cell…

Pralsetinib effective, safe for RET fusion-positive NSCLC

January 20, 2020
The investigational therapy pralsetinib appeared effective and safe for patients with RET fusion-positive non-small cell lung cancer, according to…

Physicians join John Theurer Cancer Center medical staff

January 18, 2020
John Theurer Cancer Center at Hacksensack University Cancer Center announced the appointment of five physicians to its medical staff.

In the Journals

High BMI linked to longer survival with immunotherapy for non-small cell lung cancer

January 16, 2020
High baseline BMI appeared to be independently associated with improved survival among patients with non-small cell lung cancer who received…

FDA News

FDA grants priority review to Opdivo-Yervoy combination for first-line non-small cell lung cancer

January 15, 2020
The FDA granted priority review to the combination of nivolumab plus ipilimumab for the first-line treatment of patients with metastatic or recurrent…

Addition of pembrolizumab to chemotherapy fails to extend OS in small cell lung cancer

January 14, 2020
The addition of pembrolizumab to first-line chemotherapy extended PFS but failed to significantly extend OS among patients with extensive-stage small…

In the JournalsPerspective

Cancer mortality rate drops 29% between 1991 and 2017

January 8, 2020
Cancer mortality rates dropped by 29% between 1991 and 2017 in the United States, with a 2.2% drop between 2016 and 2017, according to according to…

FDA News

FDA grants orphan drug designation to HSB-1216 for small cell lung cancer

January 6, 2020
The FDA granted orphan drug designation to HSB-1216 for the treatment of small cell lung cancer, according to the agent’s manufacturer. The…


‘So many are dying’: Screening guidelines miss lung cancer among first responders

December 31, 2019
Occupational exposure to carcinogens often is overshadowed by smoking as a risk factor for lung cancer, yet it has been linked to an estimated 30% of…

Healio's top pulmonology news from 2019: Updates in asthma, COPD, vaping-related lung injury and more

December 31, 2019
As 2019 comes to a close, the Healio Pulmonology Editors have compiled a list of the most-read articles published this year. Our readers were…

GO2 Foundation presents Young Innovators Team Awards for lung cancer research

December 6, 2019
GO2 Foundation for Lung Cancer announced the recipients of its 2019 Young Innovators Team Awards. The awards are designed to encourage creative…

Top pulmonology news from November: ACAAI coverage, pneumonia research and more

December 2, 2019
Healio Pulmonology has you covered. The Editors have compiled a list of popular articles posted on Healio Pulmonology in November. See below for…

FDA grants priority review to Imfinzi for lung cancer subset

December 2, 2019
The FDA granted priority review to a supplemental biologics license application that seeks approval of durvalumab for previously untreated…

International Association for the Study of Lung Cancer appoints chief science officer

November 30, 2019
International Association for the Study of Lung Cancer appointed Chandra P. Belani, MD, as its new chief science officer. Belani will direct and…

In the Journals

Study links air pollution to nine causes of death

November 26, 2019
A new study has identified nine specific causes of death that are related to exposure to ambient fine particulate matter air pollution. Moreover…

Meeting News

Brigatinib confers durable PFS benefit in ALK-positive NSCLC

November 24, 2019
Brigatinib conferred a durable PFS benefit compared with crizotinib among patients with ALK-positive non-small cell lung cancer who had not received…

Meeting News

Best of CHEST: Updates in asthma, COPD, bronchoscopy and more

November 18, 2019
This year’s CHEST Annual Meeting, held from Oct. 19 to 23 in New Orleans, highlighted important research and issues in pulmonary, critical care…

Meeting NewsPerspective

Novel blood tests could improve cancer detection

November 14, 2019
Two novel blood assays demonstrated efficacy in detecting various cancer types at different disease stages, according to results of two studies…

Healio Jobs